Sidewinder Therapeutics
PrivateLast Round
Series B
Apr 8, 2026
Total Funding Raised
$187M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sidewinder Therapeutics is a biopharmaceutical company that develops next-generation bispecific antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sidewinder Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Sidewinder Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 8, 2026 | ||||
| Series A | Oct 25, 2023 |
Key People
Founding team and executive leadership
Sidewinder Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series B |
| Life Sciences at Goldman Sachs Alternatives | Series B |
| OrbiMed | Series B, Series A |
| Frazier Life Sciences | Series B |
| Alexandria Venture Investments | Series B |
| Astellas Venture Management | Series B |
| Goldman Sachs Alternatives | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 189% MoM, reaching 3.1K.
- Apr 8, 2026
$137M round raised.
Sidewinder Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sidewinder Therapeutics's valuation, stock price, and market status.